DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02722044 (ClinicalTrials.gov)	April 2016	23/3/2016	Usability of an AI for M923 in Subjects With Moderate to Severe RA	An Open-label Single-arm Multicenter Study to Evaluate Usability of a Subcutaneous (SC) Autoinjector (AI) for a Proposed Adalimumab Biosimilar (M923) in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)	Rheumatoid Arthritis	Biological: M923;Device: Autoinjector	Momenta Pharmaceuticals, Inc.	NULL	Completed	18 Years	N/A	All	33	Phase 3	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02722044
(ClinicalTrials.gov)

April 2016

23/3/2016

Usability of an AI for M923 in Subjects With Moderate to Severe RA

An Open-label Single-arm Multicenter Study to Evaluate Usability of a Subcutaneous (SC) Autoinjector (AI) for a Proposed Adalimumab Biosimilar (M923) in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Biological: M923;Device: Autoinjector

Momenta Pharmaceuticals, Inc.

NULL

Completed

18 Years

N/A

All

Phase 3

United States